Myosin light chain replacement in the heart.

Area of Science:

• Cardiovascular Physiology
• Muscle Contraction Biochemistry

Background:

• Myosin-actin cross-bridge kinetics are crucial for cardiac systolic and diastolic function.
• Understanding these kinetics is key to comprehending heart muscle performance.

Purpose of the Study:

• To investigate the impact of myosin light chain substitutions on cardiac fiber contractility and power generation.
• To determine if alterations in myosin heavy chain kinetics affect cardiac remodeling and hypertrophy.

Main Methods:

• Utilized transgenesis for complete replacement of target contractile protein isoforms in the heart.
• Skinned atrial and ventricular fibers were analyzed for force-velocity relationships, unloaded shortening velocities, and ATPase activity.
• Engineered modified alpha-myosin heavy chain isoforms to assess force development changes.

Main Results:

• Myosin light chain isoform replacement significantly altered cross-bridge cycling kinetics without adverse effects on morbidity or mortality.
• Modified alpha-myosin heavy chain isoforms changed force development without causing significant cardiac remodeling or hypertrophy.
• Animals with modified myosin isoforms maintained normal lifespans and health.

Conclusions:

• Myosin light chains play a role in controlling cross-bridge cycling kinetics and modulating force development in cardiac muscle.
• Alterations in myosin heavy chain kinetics do not necessarily trigger cardiac hypertrophy or significant remodeling.
• Cardiac function can be modified through myosin isoform engineering without detrimental health outcomes.